# AI diagnosis from medical images: Industries

Source page: https://www.materialinsights.org/technologies/ai_medical_imaging/tech-industries/

#### Industries

The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
 Used by

- [Diagnostic laboratories and imaging centres](https://www.materialinsights.org/industries/healthcare/) Faster reading and triage Imaging centres and radiology departments use most products; 76.5% of US AI device authorisations to 2025 were in radiology ^[6].
- [Primary care clinics and doctors' practices](https://www.materialinsights.org/industries/healthcare/) Screening without a specialist IDx-DR was tested on 900 patients with diabetes at 10 primary care sites ^[3, 9].
 Made by

- [Medical-device companies (OEMs)](https://www.materialinsights.org/industries/medical_devices/) Software as a medical device Each product is regulated as a medical device; the FDA had authorised more than 1,600 by 2026 ^[4].
- [AI and digital platforms](https://www.materialinsights.org/industries/ai_platforms/) Research and products Technology firms such as Google developed some of the best-known systems ^[2].
 Transforms

- [Device regulators and notified bodies](https://www.materialinsights.org/industries/medical_devices/) New review rules Regulators had to decide how to authorise software that makes a diagnosis on its own, starting with IDx-DR in 2018 ^[3].

as of 2026-11-11

#### Sources

1. [Deep Learning for Detection of Diabetic Eye Disease (29 November 2016)](https://research.google/blog/deep-learning-for-detection-of-diabetic-eye-disease/) Google Research blog (L. Peng and V. Gulshan), 2016
2. [FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems](https://www.hcinnovationgroup.com/clinical-it/article/13009587/fda-permits-marketing-of-artificial-intelligence-based-device-to-detect-certain-diabetes-related-eye-problems) Healthcare Innovation (HCI Innovation Group), reproducing the FDA news release of 11 April 2018, 2018
3. [Artificial Intelligence-Enabled Medical Devices](https://www.fda.gov/medical-devices/digital-health-center-excellence/artificial-intelligence-enabled-medical-devices) US Food and Drug Administration, 2026
4. [Radiology dominates thirty years of FDA AI device approvals](https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15830219/radiology-dominates-thirty-years-of-fda-ai-device-approvals) AuntMinnie (Will Morton, 16 July 2026), reporting a study by P. Golshani and others in Cureus (doi 10.7759/cureus.112583), which could not be opened, 2026
5. [De Novo classification request for IDx-DR (decision summary, DEN180001)](https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN180001.pdf) US Food and Drug Administration, 2018

## Other sections

- [Summary](https://www.materialinsights.org/technologies/ai_medical_imaging/index.md)
- [Overview](https://www.materialinsights.org/technologies/ai_medical_imaging/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/ai_medical_imaging/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/ai_medical_imaging/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/ai_medical_imaging/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/ai_medical_imaging/tech-energy-footprint/index.md)
